Katyal Abhay, Li Christopher O Y, Franciosi Sonia, Sanatani Shubhayan
British Columbia Children's Hospital Heart Center, Department of Pediatrics, University of British Columbia, Vancouver, BC, Canada.
Front Pediatr. 2023 Apr 4;11:1151286. doi: 10.3389/fped.2023.1151286. eCollection 2023.
Sudden cardiac death (SCD) is a rare and devastating event in children and remains a leading cause of death in young athletes. Channelopathies and cardiomyopathies, in particular long QT syndrome (LQTS), catecholaminergic polymorphic ventricular tachycardia (CPVT), hypertrophic cardiomyopathy (HCM), and arrhythmogenic cardiomyopathy (ACM) are associated with exercise-related SCD. Implantable cardioverter-defibrillators (ICDs) are often placed for secondary prevention for athletes with cardiomyopathy or channelopathy. There remains concern regarding the safety of return to participation with an ICD in place. Guidelines have historically recommended that patients with inherited heart rhythm disorders be restricted from competitive sports participation. Increasing evidence suggests a lower risk of exercise-related cardiac events in young athletes with inherited heart rhythm disorders. In this review, we highlight current knowledge, evolving guidelines, and present a multidisciplinary approach involving shared decision-making and appropriate planning for safe sports participation of children with inherited heart rhythm disorders.
心脏性猝死(SCD)在儿童中是一种罕见且具有毁灭性的事件,仍是年轻运动员死亡的主要原因。离子通道病和心肌病,特别是长QT综合征(LQTS)、儿茶酚胺能多形性室性心动过速(CPVT)、肥厚型心肌病(HCM)和致心律失常性心肌病(ACM)与运动相关的SCD有关。植入式心脏复律除颤器(ICD)通常用于对患有心肌病或离子通道病的运动员进行二级预防。对于植入ICD后恢复运动的安全性仍存在担忧。历史上的指南建议,患有遗传性心律紊乱的患者应限制参加竞技体育活动。越来越多的证据表明,患有遗传性心律紊乱的年轻运动员发生运动相关心脏事件的风险较低。在这篇综述中,我们强调了当前的知识、不断演变的指南,并提出了一种多学科方法,包括共同决策和为患有遗传性心律紊乱的儿童安全参与运动进行适当规划。